ROMANELLI, ROBERTO GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 10.577
EU - Europa 6.411
AS - Asia 3.588
SA - Sud America 397
AF - Africa 90
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 41
Totale 21.184
Nazione #
US - Stati Uniti d'America 10.397
RU - Federazione Russa 2.146
IT - Italia 1.170
SG - Singapore 1.057
PL - Polonia 811
CN - Cina 751
HK - Hong Kong 671
SE - Svezia 581
IE - Irlanda 539
VN - Vietnam 382
BR - Brasile 319
KR - Corea 280
DE - Germania 257
UA - Ucraina 230
FI - Finlandia 193
FR - Francia 162
GB - Regno Unito 143
IN - India 106
CA - Canada 102
AU - Australia 78
CH - Svizzera 77
TR - Turchia 66
JP - Giappone 56
JO - Giordania 43
BD - Bangladesh 35
AR - Argentina 27
CI - Costa d'Avorio 27
MX - Messico 27
NL - Olanda 27
IQ - Iraq 23
PK - Pakistan 23
BE - Belgio 20
ID - Indonesia 19
NG - Nigeria 16
UZ - Uzbekistan 15
VE - Venezuela 15
CO - Colombia 14
JM - Giamaica 14
ES - Italia 13
HN - Honduras 11
ZA - Sudafrica 11
MA - Marocco 10
TT - Trinidad e Tobago 8
BG - Bulgaria 7
EC - Ecuador 7
MY - Malesia 7
SA - Arabia Saudita 7
AL - Albania 6
PH - Filippine 6
SC - Seychelles 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
AT - Austria 4
CR - Costa Rica 4
DZ - Algeria 4
KE - Kenya 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
EU - Europa 3
GT - Guatemala 3
KG - Kirghizistan 3
KZ - Kazakistan 3
OM - Oman 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
NI - Nicaragua 2
PR - Porto Rico 2
SV - El Salvador 2
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
EE - Estonia 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
Totale 21.136
Città #
Santa Clara 2.018
Ashburn 904
Fairfield 859
Warsaw 806
Singapore 719
Chandler 593
Hong Kong 550
Dublin 538
Woodbridge 432
San Jose 393
Seattle 378
Cambridge 374
Jacksonville 365
Houston 310
Wilmington 306
Seoul 273
Milan 270
Beijing 237
Ann Arbor 164
The Dalles 161
Council Bluffs 151
Buffalo 150
Princeton 134
Ho Chi Minh City 124
Los Angeles 123
Boston 113
Lawrence 113
Dallas 107
Rome 107
Boardman 104
Altamura 100
Lauterbourg 99
Hanoi 85
Florence 81
Melbourne 77
Bern 70
Hefei 70
Mumbai 66
Munich 61
San Diego 55
Tokyo 55
Moscow 53
New York 53
Medford 50
Izmir 45
Shanghai 44
Chicago 42
Paris 41
Helsinki 35
São Paulo 34
Columbus 32
Kent 32
Phoenix 32
Naples 31
Turku 30
Redondo Beach 29
Turin 29
Dearborn 28
Abidjan 27
Bologna 27
Norwalk 26
London 24
Orem 24
Bremen 23
Brooklyn 23
Toronto 23
Da Nang 22
Montreal 22
Palermo 19
Abuja 16
Washington 16
Atlanta 15
Brussels 14
Frankfurt Am Main 14
Frankfurt am Main 14
Philadelphia 14
Tashkent 14
Verona 14
Chennai 13
Hillsboro 13
Andover 12
Auburn Hills 12
Denver 12
Falls Church 12
Guangzhou 12
Miano 12
Catania 11
Haiphong 11
Jakarta 11
Manchester 11
San Francisco 11
Baghdad 10
Bari 10
Dong Ket 10
Kingston 10
Nanjing 10
Venice 10
Amman 8
Brescia 8
Genoa 8
Totale 13.963
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 385
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 356
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 325
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 321
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. 302
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 290
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 257
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 246
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 233
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 230
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 225
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 225
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 224
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis. 215
Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. 214
ADMA correlates with portal pressure in patients with compensated cirrhosis. 212
DRESS syndrome in a patient with chronic hepatic encephalopathy. 211
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 206
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 206
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 202
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 200
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 198
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association. 198
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 197
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 197
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 196
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 196
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 195
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 194
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 193
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation from Italy 193
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 190
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 189
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 188
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 187
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 184
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 183
Screening of distress among hospitalized patients in a department of internal medicine. 183
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 182
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 181
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 181
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. 181
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 180
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 180
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 178
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 175
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 174
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 171
Organization of the lymphoid tissue in livers with chronic active hepatitis. 171
QT adaptation during exercise in cirrhosis 170
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 168
Pathogenesis and treatment of ascites in hepatic cirrhosis. 165
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 165
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 164
Torasemide in the treatment of patients with cirrhosis and ascites. 164
Progression of fibrosis in chronic liver diseases: time to tally the score. 164
The src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling 163
Hepato-systemic gradient of carbon monoxide in cirrhosis. 163
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes 160
Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells. 159
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 159
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 159
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 156
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 155
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 154
Update on ascites and hepatorenal syndrome 154
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 153
The cellular and molecular basis of liver fibrogenesis. 151
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 151
Uveitis in autoimmune hepatitis: a case report. 151
Pathogenesis and treatment of ascites in hepatic cirrhosis. 150
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. 149
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. 149
CXCR3-binding chemokines as survival factors in human hepatic stellate cells. 148
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 147
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 145
Progression of fibrosis in chronic liver diseases: time to tally the score 144
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 144
Effects of recombinant human gamma-interferon on advanced hepatocellular carcinoma 143
IGF-I IS A SURVIVAL FACTOR FOR HUMAN HEPATIC STELLATE CELLS (HSC): INVOLVEMENT OF PI 3-K AND C-AKT 143
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 142
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 142
Epatite da virus C e terapia interferonica 142
Il Fegato: Fisiopatologia, Clinica, Terapia 141
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis 140
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 139
Alcol e metabolismo proteico 138
EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION. 137
L'alcol ed il metabolismo glicidico 136
Renal impairement in chronic liver diseases with and without cholestasis 136
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 134
EFFECTS OF RECOMBINANT HUMAN GAMMA-INTERFERON ON ADVANCED HEPATOCELLULAR CARCINOMA 134
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 134
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 133
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 132
Hepatorenal syndrome and its treatment today. 132
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 129
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 128
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats 128
DIURETIC AND NATRIURETIC EFFECTS OF LONG-TERM ALBUMIN INFUSION IN PATIENTS WlTH CIRRHOSIS AND ASCITES: A RANDOMISED CONTROLLED STUDY 124
Totale 18.011
Categoria #
all - tutte 57.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 0 0 0 39 30 27 29 49 46 25 190 268
2022/20232.374 223 355 109 182 208 422 324 142 247 18 60 84
2023/2024731 22 97 142 48 49 103 26 161 9 19 30 25
2024/20255.666 161 602 381 902 1.841 614 89 323 290 115 180 168
2025/20265.354 679 768 356 246 568 185 598 220 478 312 107 837
2026/20271.000 167 226 560 47 0 0 0 0 0 0 0 0
Totale 21.184